Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 3:45 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1609–1632 of 2,006 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Discrete Clear all

Conditions: Benign Epilepsy With Centrotemporal Spikes, Language Problems, Learning Disorders
Interventions: Active rTMS, Sham rTMS; Device
Lead sponsor: Stanford University; Other
Eligibility: 5 Years to 18 Years
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Asthma
Interventions: LPS endotoxin, saline, HDM; Biological
Lead sponsor: National Institute of Environmental Health Sciences (NIEHS); NIH
Eligibility: 18 Years to 40 Years
Enrollment: 176 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2001 – 2007
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Obesity, Childhood
Interventions: ReCHARGE, TAU; Behavioral
Lead sponsor: University of Houston; Other
Eligibility: 10 Years to 17 Years
Enrollment: 392 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Glucose Control
Interventions: High Intensity Interval Training, Moderate Intensity aerobic training; Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Dry Eye, Ocular Inflammation
Interventions: Eye wash; Other
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years and older
Enrollment: 153 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Loneliness
Interventions: Interpretation Bias Modification for Loneliness, Healthy Habits Psychoeducation and Relaxation; Behavioral
Lead sponsor: Florida State University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 67 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Tallahassee, Florida

Conditions: Mental Health, Conflict
Interventions: Parent-child intervention, Self-study Intervention; Behavioral
Lead sponsor: University of Notre Dame; Other
Eligibility: 4 Years and older
Enrollment: 1,800 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2025
U.S. locations: 3
States / cities: Fort Wayne, Indiana • Indianapolis, Indiana • Notre Dame, Indiana

Conditions: Granular Dystrophy, Corneal
Interventions: Nd:YAG Laser; Device
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Osteoporosis, Postmenopausal
Interventions: Experimental: 40 minute up trial, Experimental: 40 minute down trial, Experimental: Two 20 minute up trials, Experimental: Two 20 min down trials, Active Comparator: Sedentary trial; Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 50 Years to 65 Years · Female only
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Opioid Use Disorder
Interventions: NYX-783, Placebo, Oxycodone; Drug
Lead sponsor: Yale University; Other
Eligibility: 21 Years to 58 Years
Enrollment: 9 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 2
States / cities: New Haven, Connecticut

Conditions: Myasthenic Syndromes, Congenital
Interventions: amifampridine phosphate, Placebo; Drug
Lead sponsor: Catalyst Pharmaceuticals, Inc.; Industry
Eligibility: 2 Years to 70 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 4
States / cities: Los Angeles, California • Baltimore, Maryland • Boston, Massachusetts + 1 more

Conditions: Pancreas, Mass Lesion
Interventions: Heparin will be used for needle priming (BD PosiFlush™ Pre-Filled Heparin Lock Flush Syringe), Saline; Combination Product · Drug
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Episodic Memory, Healthy
Interventions: Transcranial magnetic stimulation; Other
Lead sponsor: Boston College; Other
Eligibility: 18 Years to 35 Years
Enrollment: 41 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Chestnut Hill, Massachusetts

Conditions: Spinocerebellar Ataxia
Interventions: Transcranial Magnetic Stimulation; Device
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 18 Years to 70 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Essential Tremor, Neuromodulation
Interventions: Focused Ultrasound Neuromodulation - Sham Control, Focused ultrasound neuromodulation; Device
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: San Francisco, California

Conditions: CHOLELITHIASIS
Interventions: Single-port cholecystectomy, Four-port laparoscopic cholecystectomy; Procedure
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 118 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Heart Failure
Interventions: BNP; Diagnostic Test
Lead sponsor: Beckman Coulter, Inc.; Industry
Eligibility: 22 Years and older
Enrollment: 1,100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 17
States / cities: Loma Linda, California • Sacramento, California • Gainesville, Florida + 14 more

Conditions: Overweight, Obesity
Interventions: Family Based Behavioral Treatment, Guided Self-Help Fam. Based Bx Treatment; Behavioral
Lead sponsor: University of California, San Diego; Other
Eligibility: 7 Years to 12 Years
Enrollment: 151 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2023
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Metabolic Syndrome X
Interventions: NOS Inhibition, ET-1 Inhibition, NOS Inhibition Placebo, 3 Tesla MRI, Intravenous Catheter, Oral Glucose Tolerance Test, ET-1 Inhibition Placebo; Drug · Device · Other
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years to 45 Years
Enrollment: 59 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: CMV
Interventions: T-SPOT®.CMV Test; Diagnostic Test
Lead sponsor: St. Jude Children's Research Hospital; Other
Eligibility: Not listed
Enrollment: 11 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Growth Disorders, Insulin-Like Growth Factor-1 Deficiency
Interventions: rhIGF-1 (mecasermin, Tercica, Inc.); Drug
Lead sponsor: Ipsen; Industry
Eligibility: 3 Years to 12 Years
Enrollment: 137 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2008
U.S. locations: 1
States / cities: Brisbane, California

Conditions: Spinal Cord Injuries
Interventions: Not listed
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years and older
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Healthy
Interventions: eszopiclone, zolpidem, placebo; Drug
Lead sponsor: Kettering Health Network; Other
Eligibility: 18 Years to 35 Years · Male only
Healthy volunteers: Accepts healthy volunteers
U.S. locations: 1
States / cities: Kettering, Ohio

Conditions: Ankle Foot Orthosis (AFO), Stroke Patients, Post-Stroke Hemiparesis
Interventions: Pre-fabricated (PF) ankle-foot orthosis (AFO), Carbon-strut (CS) ankle-foot orthosis (AFO), Multifunctional articulating (MA) ankle-foot orthosis (AFO); Device
Lead sponsor: University of Texas at Austin; Other
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 4
States / cities: Downey, California • Jacksonville, Florida • Charleston, South Carolina + 1 more

Search by objective public record fields.

Transcranial Magnetic Stimulation for BECTS

The Genetics of Environmental Asthma

Teens Committed to Health Through Activity, Relationships, and Good Eating

The Effect of High-Intensity Short-Duration Exercise Versus Moderate-Intensity High-Volume Exercise on Glucose Control

Closed Eye Neutrophils in Dry Eye Disease

Computerized Intervention for Loneliness

The Happy Families Project: Testing the Effectiveness of a Conflict Resolution Program for Families

Neodymium-doped Yttrium Aluminum Garnet (Nd:YAG) Laser Treatment for Granular Corneal Dystrophy

Parameters of Exercise to Prevent Osteoporosis

Safety, Tolerability and Pharmacokinetics of NYX-783 and Oxycodone DDI Study

Amifampridine Phosphate for the Treatment of Congenital Myasthenic Syndromes

Assessing Effects of Heparin Priming and Pass Number on Tissue Quality of Fine Needle Biopsies

Causal Role of Brain Networks in Episodic Memory

Transcranial Magnetic Stimulation in Spino-Cerebellar Ataxia

Ultrasound Neuromodulation in Essential Tremor

A Comparison of Single Port and Four Port Laparoscopic Gallbladder Removal

Access BNP Clinical Enrollment Study

FRESH-DOSE: Families Responsibility Education Support Health-Dual Options for Sustained Effectiveness

Mechanisms of Cerebrovascular Control

Evaluating the Clinical Utility of the T-SPOT.CMV Assay for the Prediction of CMV Reactivation Among Pediatric Patients Undergoing Hematopoietic Cell Transplant

Prepubertal Children With Growth Failure Associated With Primary Insulin-Like Growth Factor-1 (IGF-1) Deficiency

Design and Delivery Preferences for Exercise Intervention in People With Spinal Cord Injury

Positron Emission Tomography Assessment of the Central Nervous System Effects of Eszopiclone and Zolpidem

AFO Prescription to Optimize Post-Stroke Function